BlackRock, Inc. 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS |
BlackRock Inc. BLK |
3,499,478 6.200% |
0 (Unchanged) |
Filing |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS |
BlackRock Inc. BLK |
3,499,478 6.200% |
1,043,825 (+42.51%) |
Filing |
| 2024-03-07 12:29 pm Purchase |
2024-02-29 | 13G | Astria Therapeutics, Inc. ATXS |
BlackRock Inc. BLK |
2,455,653 4.500% |
271,095 (+12.41%) |
Filing |
| 2024-01-29 5:26 pm Purchase |
2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
BlackRock Inc. BLK |
2,184,558 6.000% |
2,131,485 (+4016.14%) |
Filing |
| 2022-02-24 5:23 pm Purchase |
2021-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
BlackRock Inc. BLK |
53,073 0.400% |
53,073 (New Position) |
Filing |